239 related articles for article (PubMed ID: 22028652)
1. Soluble rhesus lymphocryptovirus gp350 protects against infection and reduces viral loads in animals that become infected with virus after challenge.
Sashihara J; Hoshino Y; Bowman JJ; Krogmann T; Burbelo PD; Coffield VM; Kamrud K; Cohen JI
PLoS Pathog; 2011 Oct; 7(10):e1002308. PubMed ID: 22028652
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr Virus gp350 Can Functionally Replace the Rhesus Lymphocryptovirus Major Membrane Glycoprotein and Does Not Restrict Infection of Rhesus Macaques.
Herrman M; Mühe J; Quink C; Wang F
J Virol; 2016 Feb; 90(3):1222-30. PubMed ID: 26559839
[TBL] [Abstract][Full Text] [Related]
3. Structural, functional, and genetic comparisons of Epstein-Barr virus nuclear antigen 3A, 3B, and 3C homologues encoded by the rhesus lymphocryptovirus.
Jiang H; Cho YG; Wang F
J Virol; 2000 Jul; 74(13):5921-32. PubMed ID: 10846073
[TBL] [Abstract][Full Text] [Related]
4. Adenovirus-based vaccines against rhesus lymphocryptovirus EBNA-1 induce expansion of specific CD8+ and CD4+ T cells in persistently infected rhesus macaques.
Leskowitz R; Fogg MH; Zhou XY; Kaur A; Silveira EL; Villinger F; Lieberman PM; Wang F; Ertl HC
J Virol; 2014 May; 88(9):4721-35. PubMed ID: 24522914
[TBL] [Abstract][Full Text] [Related]
5. Cloning of the rhesus lymphocryptovirus viral capsid antigen and Epstein-Barr virus-encoded small RNA homologues and use in diagnosis of acute and persistent infections.
Rao P; Jiang H; Wang F
J Clin Microbiol; 2000 Sep; 38(9):3219-25. PubMed ID: 10970361
[TBL] [Abstract][Full Text] [Related]
6. CD4+ and CD8+ T-cell responses to latent antigen EBNA-1 and lytic antigen BZLF-1 during persistent lymphocryptovirus infection of rhesus macaques.
Leskowitz RM; Zhou XY; Villinger F; Fogg MH; Kaur A; Lieberman PM; Wang F; Ertl HC
J Virol; 2013 Aug; 87(15):8351-62. PubMed ID: 23698300
[TBL] [Abstract][Full Text] [Related]
7. The CD8+ T-cell response to an Epstein-Barr virus-related gammaherpesvirus infecting rhesus macaques provides evidence for immune evasion by the EBNA-1 homologue.
Fogg MH; Kaur A; Cho YG; Wang F
J Virol; 2005 Oct; 79(20):12681-91. PubMed ID: 16188971
[TBL] [Abstract][Full Text] [Related]
8. Evolution of two types of rhesus lymphocryptovirus similar to type 1 and type 2 Epstein-Barr virus.
Cho YG; Gordadze AV; Ling PD; Wang F
J Virol; 1999 Nov; 73(11):9206-12. PubMed ID: 10516028
[TBL] [Abstract][Full Text] [Related]
9. Experimental rhesus lymphocryptovirus infection in immunosuppressed macaques: an animal model for Epstein-Barr virus pathogenesis in the immunosuppressed host.
Rivailler P; Carville A; Kaur A; Rao P; Quink C; Kutok JL; Westmoreland S; Klumpp S; Simon M; Aster JC; Wang F
Blood; 2004 Sep; 104(5):1482-9. PubMed ID: 15150077
[TBL] [Abstract][Full Text] [Related]
10. Persistent infection drives the development of CD8+ T cells specific for late lytic infection antigens in lymphocryptovirus-infected macaques and Epstein-Barr virus-infected humans.
Orlova N; Wang F; Fogg MH
J Virol; 2011 Dec; 85(23):12821-4. PubMed ID: 21917961
[TBL] [Abstract][Full Text] [Related]
11. An Epstein-Barr virus encoded inhibitor of Colony Stimulating Factor-1 signaling is an important determinant for acute and persistent EBV infection.
Ohashi M; Fogg MH; Orlova N; Quink C; Wang F
PLoS Pathog; 2012 Dec; 8(12):e1003095. PubMed ID: 23300447
[TBL] [Abstract][Full Text] [Related]
12. Antibodies to lytic infection proteins in lymphocryptovirus-infected rhesus macaques: a model for humoral immune responses to epstein-barr virus infection.
Orlova N; Fogg MH; Carville A; Wang F
Clin Vaccine Immunol; 2011 Sep; 18(9):1427-34. PubMed ID: 21734064
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic vaccination against the rhesus lymphocryptovirus EBNA-1 homologue, rhEBNA-1, elicits T cell responses to novel epitopes in rhesus macaques.
Silveira EL; Fogg MH; Leskowitz RM; Ertl HC; Wiseman RW; O'Connor DH; Lieberman P; Wang F; Villinger F
J Virol; 2013 Dec; 87(24):13904-10. PubMed ID: 24089556
[TBL] [Abstract][Full Text] [Related]
14. Molecular evidence for rhesus lymphocryptovirus infection of epithelial cells in immunosuppressed rhesus macaques.
Kutok JL; Klumpp S; Simon M; MacKey JJ; Nguyen V; Middeldorp JM; Aster JC; Wang F
J Virol; 2004 Apr; 78(7):3455-61. PubMed ID: 15016868
[TBL] [Abstract][Full Text] [Related]
15. Infection of human B lymphocytes with lymphocryptoviruses related to Epstein-Barr virus.
Moghaddam A; Koch J; Annis B; Wang F
J Virol; 1998 Apr; 72(4):3205-12. PubMed ID: 9525646
[TBL] [Abstract][Full Text] [Related]
16. Sequence and functional analysis of EBNA-LP and EBNA2 proteins from nonhuman primate lymphocryptoviruses.
Peng R; Gordadze AV; Fuentes Pananá EM; Wang F; Zong J; Hayward GS; Tan J; Ling PD
J Virol; 2000 Jan; 74(1):379-89. PubMed ID: 10590127
[TBL] [Abstract][Full Text] [Related]
17. High Epstein-Barr Virus Load and Genomic Diversity Are Associated with Generation of gp350-Specific Neutralizing Antibodies following Acute Infectious Mononucleosis.
Weiss ER; Alter G; Ogembo JG; Henderson JL; Tabak B; Bakiş Y; Somasundaran M; Garber M; Selin L; Luzuriaga K
J Virol; 2017 Jan; 91(1):. PubMed ID: 27733645
[TBL] [Abstract][Full Text] [Related]
18. A new animal model for Epstein-Barr virus pathogenesis.
Wang F
Curr Top Microbiol Immunol; 2001; 258():201-19. PubMed ID: 11443863
[No Abstract] [Full Text] [Related]
19. The BZLF1 homolog of an Epstein-Barr-related gamma-herpesvirus is a frequent target of the CTL response in persistently infected rhesus macaques.
Fogg MH; Garry D; Awad A; Wang F; Kaur A
J Immunol; 2006 Mar; 176(6):3391-401. PubMed ID: 16517707
[TBL] [Abstract][Full Text] [Related]
20. Summary of roundtable discussion meeting: non-human primates to assess risk for EBV-related lymphomas in humans.
Kawabata T; Weaver J; Thomas D; Rowe M; Wang F; Kamperschroer C; Haggerty H
J Immunotoxicol; 2012; 9(1):121-7. PubMed ID: 22136193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
